Antimicrobial peptides [[electronic resource] /] / [editors, Joan Marsh and Jamie A. Goode] |
Pubbl/distr/stampa | Chichester, England ; ; New York, : Wiley, 1994 |
Descrizione fisica | 1 online resource (293 p.) |
Disciplina |
574.29
615/.3 |
Altri autori (Persone) |
MarshJoan
GoodeJamie |
Collana | Ciba Foundation symposium |
Soggetto topico |
Peptide antibiotics
Protein drugs Peptides - Therapeutic use Microbial peptides |
Soggetto genere / forma | Electronic books. |
ISBN |
1-282-45501-X
9786612455018 0-470-51465-5 0-470-51466-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
ANTIMICROBIAL PEPTIDES; Chairman's opening remarks; Design and synthesis of antimicrobial peptides; Gene-encoded antibiotics made in bacteria; General discussion I; Biosynthesis of defensins and other antimicrobial peptides; Antimicrobial peptides from amphibian skin: an overview; Gene-encoded antimicrobial peptides from plants; Drosophila as a model system for antibacterial peptides; Function of antimicrobial proteins in insects; General discussion I I; Anti bacterial peptides in insect vectors of tropical parasitic disease
Structu re-f u nction relationships of tachyplesins and their analoguesBactericidal permeability-increasing protein in host defence against Gram- negative bacteria and endotoxin; General discussion I I I; Potential therapeutic applications of magainins and other antimicrobial agents of animal origin; Primitive vertebrate immunity: what is the evolutionary derivation of molecules that define the adaptive immune system?; Antimicrobial proteins with homology to serine proteases; Antimicrobial peptides as agents of mucosal immunity; Closing remarks; Index of contributors; Subject index |
Record Nr. | UNINA-9910144560203321 |
Chichester, England ; ; New York, : Wiley, 1994 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Antimicrobial peptides [[electronic resource] /] / [editors, Joan Marsh and Jamie A. Goode] |
Pubbl/distr/stampa | Chichester, England ; ; New York, : Wiley, 1994 |
Descrizione fisica | 1 online resource (293 p.) |
Disciplina |
574.29
615/.3 |
Altri autori (Persone) |
MarshJoan
GoodeJamie |
Collana | Ciba Foundation symposium |
Soggetto topico |
Peptide antibiotics
Protein drugs Peptides - Therapeutic use Microbial peptides |
ISBN |
1-282-45501-X
9786612455018 0-470-51465-5 0-470-51466-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
ANTIMICROBIAL PEPTIDES; Chairman's opening remarks; Design and synthesis of antimicrobial peptides; Gene-encoded antibiotics made in bacteria; General discussion I; Biosynthesis of defensins and other antimicrobial peptides; Antimicrobial peptides from amphibian skin: an overview; Gene-encoded antimicrobial peptides from plants; Drosophila as a model system for antibacterial peptides; Function of antimicrobial proteins in insects; General discussion I I; Anti bacterial peptides in insect vectors of tropical parasitic disease
Structu re-f u nction relationships of tachyplesins and their analoguesBactericidal permeability-increasing protein in host defence against Gram- negative bacteria and endotoxin; General discussion I I I; Potential therapeutic applications of magainins and other antimicrobial agents of animal origin; Primitive vertebrate immunity: what is the evolutionary derivation of molecules that define the adaptive immune system?; Antimicrobial proteins with homology to serine proteases; Antimicrobial peptides as agents of mucosal immunity; Closing remarks; Index of contributors; Subject index |
Record Nr. | UNINA-9910677028803321 |
Chichester, England ; ; New York, : Wiley, 1994 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Marine Proteins and Peptides / / edited by Se-Kwon Kim |
Pubbl/distr/stampa | Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , [2018] |
Descrizione fisica | 1 online resource (476 pages) |
Disciplina | 333.9164 |
Soggetto topico |
Marine resources
Proteins - Therapeutic use Peptides - Therapeutic use |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | About the Special Issue Editor -- Preface to "Marine Proteins and Peptides" -- Identification of Angiotensin I‐Converting Enzyme Inhibitory Peptides Derived from Enzymatic Hydrolysates of Razor Clam Sinonovacula constricta -- Coral Carbonic Anhydrases: Regulation by Ocean Acidification -- Recombinant Expression of a Modified Shrimp Anti‐Lipopolysaccharide Factor Gene in Pichia pastoris GS115 and Its Characteristic Analysis -- Anticancer Activity of a Hexapeptide from Skate (Raja porosa) Cartilage Protein Hydrolysate in HeLa Cells -- An Overview of the Medical Applications of Marine Skeletal Matrix Proteins -- Marine Microbiological Enzymes: Studies with Multiple Strategies and Prospects -- Purification of Antioxidant Peptides by High Resolution Mass Spectrometry from Simulated Gastrointestinal Digestion Hydrolysates of Alaska Pollock (Theragra chalcogramma) Skin Collagen -- Enzymatic Pre‐Treatment Increases the Protein Bioaccessibility and Extractability in Dulse (Palmaria palmata) -- Natural Proline‐Rich Cyclopolypeptides from Marine Organisms: Chemistry, Synthetic Methodologies and Biological Status -- Preclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides-A Review -- Alkynyl‐Containing Peptides of Marine Origin: A Review -- Anti‐Fatigue Effect by Peptide Fraction from Protein Hydrolysate of Croceine Croaker (Pseudosciaena crocea) Swim Bladder through Inhibiting the Oxidative Reactions including DNA Damage -- Antimicrobial and Antitumor Activities of Novel Peptides Derived from the Lipopolysaccharide‐ and β‐1,3‐Glucan Binding Protein of the Pacific Abalone Haliotis discus hannai -- Protective Effects of Hydrolyzed Nucleoproteins from Salmon Milt against Ethanol‐Induced Liver Injury in Rats -- Novel Peptide with Specific Calcium‐Binding Capacity from Schizochytrium sp. Protein Hydrolysates and Calcium Bioavailability in Caco‐2 Cells -- In vitro Anti‐Thrombotic Activity of Extracts from Blacklip Abalone (Haliotis rubra) Processing Waste -- Biochemical and Structural Insights into a Novel Thermostable β‐1,3‐Galactosidase from Marinomonas sp. BSi20414 -- Preparation of Antioxidant Peptides from Salmon Byproducts with Bacterial Extracellular Proteases -- Marine Antifreeze Proteins: Structure, Function, and Application to Cryopreservation as a Potential Cryoprotectant -- Enzyme‐Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review -- Purification and Identification of Antioxidant Peptides from Protein Hydrolysate of Scalloped Hammerhead (Sphyrna lewini) Cartilage -- Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non‐Communicable Diseases -- Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus-A Prospect -- In Vitro Antioxidant Activities of Enzymatic Hydrolysate from Schizochytrium sp. and Its Hepatoprotective Effects on Acute Alcohol‐Induced Liver Injury In Vivo -- Hydrolysates of Fish Skin Collagen: An Opportunity for Valorizing Fish Industry Byproducts -- Marine Fish Proteins and Peptides for Cosmeceuticals: A Review -- Microbial Diseases of Bivalve Mollusks: Infections, Immunology and Antimicrobial Defense. |
Record Nr. | UNINA-9910598195203321 |
Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , [2018] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Peptide and protein vaccines / / edited by Rossen Donev |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (192 p.) |
Disciplina | 572.65 |
Collana | Advances in Protein Chemistry and Structural Biology |
Soggetto topico |
Peptides - Therapeutic use
Proteins - Therapeutic use Peptide drugs |
Soggetto genere / forma | Electronic books. |
ISBN |
0-12-802869-6
0-12-802827-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Peptide and Protein Vaccines; Copyright; Contents; Contributors; Preface; References; Chapter 1: Peptide Immunotherapy in Vaccine Development: From Epitope to Adjuvant; 1. Introduction; 2. Cancer Vaccine; 3. Allergy Vaccine; 4. Alzheimerś Disease Vaccine; 5. Adjuvant and Delivery; 6. Perspectives and Conclusions; References; Chapter 2: The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against...; 1. Introduction; 2. MPER: ASite of Vulnerability on HIV-1 Env and a Linear Epitope; 3. Structural Organization of MPER
3.1. Hydrophobicity Distribution3.2. MPER Peptide Structure; 4. Lipid Vesicles: Adjuvants and Devices to Shape MPER Structure; 4.1. Liposomes as Adjuvants; 4.2. The Lipid Bilayer as an MPER Scaffold; 5. Immunogenicity Studies of MPER-Derived Peptides in Liposomes; References; Chapter 3: Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant; 1. Introduction; 2. Establishment of High Expression Recombinant Lipoprotein System; 3. The Lipid Structure of Lipoprotein; 4. Recombinant Lipoprotein with Intrinsic Adjuvant Properties 5. To Engineer Chimeric Lipoproteins with Intrinsic Adjuvant for Novel Vaccine Development6. Recombinant Chimeric Lipoproteins Can Activate BMDCs; 7. A Robustness Up- and Downstream Processes for Lipoprotein Production; 8. Recombinant Lipoprotein-Based Subunit Vaccine Induces High Titers of Neutralizing Antibody and Longer Memory Immune Re...; 9. Recombinant Lipidated Human Papillomavirus E7 Induces Cellular Immune Responses and Protective Immunity Against Cervic...; 10. Conclusion; Acknowledgment; References Chapter 4: Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers1. Introduction; 2. Licensed Adjuvants; 3. CpG-DNA: Adjuvant; 4. Phosphodiester Bond CpG-DNA; 5. Liposomes: Adjuvants; 6. Adjuvants for Peptide Vaccine; 7. Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.1. Antibody Production with Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.2. Prevention of Influenza A Virus Infection; 7.3. Prevention of Respiratory Syncytial Virus Infection 7.4. Cancer Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers8. Perspectives; Acknowledgments; References; Chapter 5: Chemical Platforms for Peptide Vaccine Constructs; 1. Introduction; 2. Multiple Antigenic Peptide System Using a PolyLys Core: ABoon to Synthetic Peptide Vaccines; 3. Synthetic Antigen Carrier Bearing N-(S-acetylmercaptoacetyl)-Glutamyl Residues; 4. Thioester as a Replacement for Natural Peptide Bond (Chemical Ligation): Construction of Proteins; 5. Synthetic Peptide Dendrimer with Thiazolidinyl Pendant 6. Oxime Chemistry for Synthetic Peptide-Based Vaccines |
Record Nr. | UNINA-9910460999503321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Peptide and protein vaccines / / edited by Rossen Donev |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (192 p.) |
Disciplina | 572.65 |
Collana | Advances in Protein Chemistry and Structural Biology |
Soggetto topico |
Peptides - Therapeutic use
Proteins - Therapeutic use Peptide drugs |
ISBN |
0-12-802869-6
0-12-802827-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Peptide and Protein Vaccines; Copyright; Contents; Contributors; Preface; References; Chapter 1: Peptide Immunotherapy in Vaccine Development: From Epitope to Adjuvant; 1. Introduction; 2. Cancer Vaccine; 3. Allergy Vaccine; 4. Alzheimerś Disease Vaccine; 5. Adjuvant and Delivery; 6. Perspectives and Conclusions; References; Chapter 2: The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against...; 1. Introduction; 2. MPER: ASite of Vulnerability on HIV-1 Env and a Linear Epitope; 3. Structural Organization of MPER
3.1. Hydrophobicity Distribution3.2. MPER Peptide Structure; 4. Lipid Vesicles: Adjuvants and Devices to Shape MPER Structure; 4.1. Liposomes as Adjuvants; 4.2. The Lipid Bilayer as an MPER Scaffold; 5. Immunogenicity Studies of MPER-Derived Peptides in Liposomes; References; Chapter 3: Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant; 1. Introduction; 2. Establishment of High Expression Recombinant Lipoprotein System; 3. The Lipid Structure of Lipoprotein; 4. Recombinant Lipoprotein with Intrinsic Adjuvant Properties 5. To Engineer Chimeric Lipoproteins with Intrinsic Adjuvant for Novel Vaccine Development6. Recombinant Chimeric Lipoproteins Can Activate BMDCs; 7. A Robustness Up- and Downstream Processes for Lipoprotein Production; 8. Recombinant Lipoprotein-Based Subunit Vaccine Induces High Titers of Neutralizing Antibody and Longer Memory Immune Re...; 9. Recombinant Lipidated Human Papillomavirus E7 Induces Cellular Immune Responses and Protective Immunity Against Cervic...; 10. Conclusion; Acknowledgment; References Chapter 4: Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers1. Introduction; 2. Licensed Adjuvants; 3. CpG-DNA: Adjuvant; 4. Phosphodiester Bond CpG-DNA; 5. Liposomes: Adjuvants; 6. Adjuvants for Peptide Vaccine; 7. Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.1. Antibody Production with Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.2. Prevention of Influenza A Virus Infection; 7.3. Prevention of Respiratory Syncytial Virus Infection 7.4. Cancer Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers8. Perspectives; Acknowledgments; References; Chapter 5: Chemical Platforms for Peptide Vaccine Constructs; 1. Introduction; 2. Multiple Antigenic Peptide System Using a PolyLys Core: ABoon to Synthetic Peptide Vaccines; 3. Synthetic Antigen Carrier Bearing N-(S-acetylmercaptoacetyl)-Glutamyl Residues; 4. Thioester as a Replacement for Natural Peptide Bond (Chemical Ligation): Construction of Proteins; 5. Synthetic Peptide Dendrimer with Thiazolidinyl Pendant 6. Oxime Chemistry for Synthetic Peptide-Based Vaccines |
Record Nr. | UNINA-9910797252503321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Peptide and protein vaccines / / edited by Rossen Donev |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
Descrizione fisica | 1 online resource (192 p.) |
Disciplina | 572.65 |
Collana | Advances in Protein Chemistry and Structural Biology |
Soggetto topico |
Peptides - Therapeutic use
Proteins - Therapeutic use Peptide drugs |
ISBN |
0-12-802869-6
0-12-802827-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Peptide and Protein Vaccines; Copyright; Contents; Contributors; Preface; References; Chapter 1: Peptide Immunotherapy in Vaccine Development: From Epitope to Adjuvant; 1. Introduction; 2. Cancer Vaccine; 3. Allergy Vaccine; 4. Alzheimerś Disease Vaccine; 5. Adjuvant and Delivery; 6. Perspectives and Conclusions; References; Chapter 2: The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against...; 1. Introduction; 2. MPER: ASite of Vulnerability on HIV-1 Env and a Linear Epitope; 3. Structural Organization of MPER
3.1. Hydrophobicity Distribution3.2. MPER Peptide Structure; 4. Lipid Vesicles: Adjuvants and Devices to Shape MPER Structure; 4.1. Liposomes as Adjuvants; 4.2. The Lipid Bilayer as an MPER Scaffold; 5. Immunogenicity Studies of MPER-Derived Peptides in Liposomes; References; Chapter 3: Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant; 1. Introduction; 2. Establishment of High Expression Recombinant Lipoprotein System; 3. The Lipid Structure of Lipoprotein; 4. Recombinant Lipoprotein with Intrinsic Adjuvant Properties 5. To Engineer Chimeric Lipoproteins with Intrinsic Adjuvant for Novel Vaccine Development6. Recombinant Chimeric Lipoproteins Can Activate BMDCs; 7. A Robustness Up- and Downstream Processes for Lipoprotein Production; 8. Recombinant Lipoprotein-Based Subunit Vaccine Induces High Titers of Neutralizing Antibody and Longer Memory Immune Re...; 9. Recombinant Lipidated Human Papillomavirus E7 Induces Cellular Immune Responses and Protective Immunity Against Cervic...; 10. Conclusion; Acknowledgment; References Chapter 4: Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers1. Introduction; 2. Licensed Adjuvants; 3. CpG-DNA: Adjuvant; 4. Phosphodiester Bond CpG-DNA; 5. Liposomes: Adjuvants; 6. Adjuvants for Peptide Vaccine; 7. Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.1. Antibody Production with Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers; 7.2. Prevention of Influenza A Virus Infection; 7.3. Prevention of Respiratory Syncytial Virus Infection 7.4. Cancer Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers8. Perspectives; Acknowledgments; References; Chapter 5: Chemical Platforms for Peptide Vaccine Constructs; 1. Introduction; 2. Multiple Antigenic Peptide System Using a PolyLys Core: ABoon to Synthetic Peptide Vaccines; 3. Synthetic Antigen Carrier Bearing N-(S-acetylmercaptoacetyl)-Glutamyl Residues; 4. Thioester as a Replacement for Natural Peptide Bond (Chemical Ligation): Construction of Proteins; 5. Synthetic Peptide Dendrimer with Thiazolidinyl Pendant 6. Oxime Chemistry for Synthetic Peptide-Based Vaccines |
Record Nr. | UNINA-9910818574903321 |
Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|